• Nenhum resultado encontrado

Arq Bras Endocrinol Metab vol.52 número3

N/A
N/A
Protected

Academic year: 2018

Share "Arq Bras Endocrinol Metab vol.52 número3"

Copied!
1
0
0

Texto

(1)

576

Arq Bras Endrocrinol Metab 2008;52/3

cop

yr

ight

© ABE&M todos os dir

eitos r

eser

v

ados

erratas

S

ÍNDROMEDE

K

ALLMANN

:

UMAREVISÃOHISTÓRICA

,

CLÍNICAEMOLECULAR

:

ERRATA

ROGÉRIO SILICANI RIBEIRO, JULIO ABUCHAM

C

ORREÇÃODOARTIGO

:

S

ÍNDROMEDE

K

ALLMANN

:

UMAREVISÃOHISTÓRICA

,

CLÍNICAEMOLECULAR

A

RQ

B

RAS

E

NDOCRINOL

M

ETAB

2008 52(1):8-17

N

OTÍTULOEMINGLÊS

,

ONDESELÊ

: K

ALLMANNSYNDROME

:

AHYSTORICAL

,

CLINICALANDMOLECULAR REVIEW

L

EIA

-

SE

: K

ALLMANNSYNDROME

:

AHISTORICAL

,

CLINICALANDMOLECULARREVIEW

T

HECORRECTTITLEIS

: K

ALLMANNSYNDROME

:

AHISTORICAL

,

CLINICALANDMOLECULARREVIEW

U

PDATE ONTHE ETIOLOGY

,

DIAGNOSIS AND THERAPEUTIC MANAGEMENT OF SEXUAL PRECOCITY

:

ERRATA

VINICIUS NAHIME BRITO, ANA CLAUDIA LATRONICO, IVO J. P. ARNHOLD, BERENICE BILHARINHO

MENDONCA

C

ORREÇÃODOARTIGO

:

U

PDATE ON THEETIOLOGY

,

DIAGNOSISAND THERAPEUTICMANAGEMENTOFSEXUALPRECOCITY

.

A

RQ

B

RAS

E

NDOCRINOL

M

ETABOL

. 2008 F

EB

;52(1):18-31.

N

A PÁGINA

P

ÁGINA

21,

NO FINAL DO PARÁGRAFO

1,

ONDE SE LÊ

: S

URGICAL TREATMENT IS RESERVED FOR LARGE HAMARTOMAS WITH NEUROLOGICAL SYMPTOMS THAT ARE DIFFICULT TO

CONTROLORINTHERARECASESOFTUMORGROWTH

(

NÃOSERIA

REGROWTH

”?).

L

EIA

-

SE

: S

URGICAL TREATMENT IS RESERVED FOR LARGE HAMARTOMAS WITH NEUROLOGICAL SYMPTOMSTHATAREDIFFICULTTOCONTROLORINTHERARECASESOFTUMORGROWTH

.

N

A PÁGINA

27,

NA ÚLTIMASENTEÇA DO SEGUNDO PARÁGRAFO

: T

HIS CONDITION TREATMENT CONSISTS OF DRUGS THAT BLOCK THE ADRENAL AND TESTICULAR SYNTHESIS OF ANDROGENS

(

KETOCONAZOL

)

AND

/

OR ANDROGENIC RECEPTOR BLOCKAGE

(

CYPROTERONE ACETATE

),

ESTROGENRECEPTORBLOCKERSANDAROMATASEINHIBITORS

.

L

EIA

-

SE

: T

HISCONDITIONTREATMENTCONSISTSOFDRUGSTHATBLOCKTHEADRENALANDTESTICULAR SYNTHESIS OF ANDROGENS

(

KETOCONAZOL

)

AND

/

OR ANDROGENIC RECEPTOR BLOCKAGE

(

CYPROTERONEACETATE

)

ANDAROMATASEINHIBITORS

.

T

RIIODOTHYRONINE

(T3)

DOESNOTINDUCE

RANKL E

XPRESSIONIN

R

AT

ROS 17/2.8 C

ELLS

:

ERRATA

PATRÍCIA P. SARAIVA, SILVANIA S. TEIXEIRA, CARLOS ROBERTO PADOVANI, CÉLIA REGINA

NOGUEIRA

C

ORREÇÃODOARTIGO

:

T

RIIODOTHYRONINE

(

T

3) D

OES

N

OT

I

NDUCE

RANKL E

XPRESSION

I

N

R

AT

ROS 17/2.8 C

ELLS

-

A

RQ

B

RAS

E

NDOCRINOL

M

ETABOL

. 2008 F

EB

;52(1):109-13.

E

MAUTORES

,

ONDESELÊ

:

P

ATRÍCIA

P. S

ARAIVA

, S

ILVANIA

S. T

EIXEIRA

, C

ÉLIA

R

EGINA

N

OGUEIRA

,

C

ARLOS

R

OBERTO

P

ADOVANI

A

ORDEMCORRETADOSAUTORESÉ

:

P

ATRÍCIA

P. S

ARAIVA

, S

ILVANIA

S. T

EIXEIRA

, C

ARLOS

R

OBERTO

Referências

Documentos relacionados

In contrast, two studies showed that the bone mineral density of the lumbar spine, femoral neck and the midshaft of the radius were not signifi cantly decreased in

Results: Patient 1: newborn with genital ambiguity; he developed Wilms tumor (WT) and chronic renal disease and died at the age of 10 months; the heterozygous 1186G>A

Functional studies of the mutant receptors of fi broblast primary culture, from patients’ skin biopsy treated with increasing doses of 1,25(OH) 2 vitamin D showed that VDR

Also, lipodystrophy and metabolic complications associated with insulin resistance have been reported in Mandibuloacral Dysplasia (18), and some affected patients were found to

The presence of PRKAR1A loss of heterozygosity (LOH) in adrenocortical tumorigenesis remains controver- sial. The aim of the present study is to investigate the presence of PRKAR1A

A novel growth hormone receptor gene deletion mutation in a patient with primary growth hormone insensitivity syndrome (Laron syndrome).. Growth Horm

The present study aim to evaluate whether urinary albumin concentration (UAC) and urinary albumin-to-creatinine ratio (UACR) agree with 24 h urine collection in screening

The autosomal recessive inheritance was reported in one family but most patients present an autosomal dominant inheritance and more than 50 mutations, causing autosomal